StockClub

NTLA

NTLAIntellia Therapeutics, Inc.$ --
Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc.

NTLA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
23M USD
YoY +78.8%
Operating Income
-99M USD
YoY +27.7%
Net Income
-96M USD
YoY +25.7%
EPS
-0.83$
YoY +34.6%

Revenue

$67.7M
FY2024 Q1$28.9M
$28.9M
Q1
FY2024 Q2$35.9M
$35.9M
Q2
FY2024 Q3$45M
$45M
Q3
FY2024 Q4$57.9M
$57.9M
Q4
FY2025 Q1$16.6M
$16.6M
Q1
FY2025 Q2$30.9M
$30.9M
Q2
FY2025 Q3$44.7M
$44.7M
Q3
FY2025 Q4$67.7M
$67.7M
Q4
Actual
+$9.8M (+16.9%)

Net Income

$-412.7M
FY2024 Q1$-107.4M
$-107.4M
Q1
FY2024 Q2$-254.4M
$-254.4M
Q2
FY2024 Q3$-390.1M
$-390.1M
Q3
FY2024 Q4$-519M
$-519M
Q4
FY2025 Q1$-114.3M
$-114.3M
Q1
FY2025 Q2$-215.6M
$-215.6M
Q2
FY2025 Q3$-316.9M
$-316.9M
Q3
FY2025 Q4$-412.7M
$-412.7M
Q4
Actual
+$106.3M (+20.5%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$58M
Est:$66.7M
FY2020MISS
$58M
FY2021BEAT
Actual:$33.1M
Est:$29.2M
FY2021BEAT
$33.1M
FY2022BEAT
Actual:$52.1M
Est:$51.9M
FY2022BEAT
$52.1M
FY2023MISS
Actual:$36.3M
Est:$46M
FY2023MISS
$36.3M
FY2024BEAT
Actual:$57.9M
Est:$53.9M
FY2024BEAT
$57.9M
FY2025BEAT
Actual:$67.7M
Est:$56.6M
FY2025BEAT
$67.7M

Analyst Estimates